Studies in this laboratory show that BA inhibits prostate cancer cell and tumor (xenograft) growth and this is due, in part, to proteasome-dependent downregulation of Sp1, Sp3, Sp4 and several Sp-regulated genes [20]. This evidence concerns the gene TFF2 and prostate cancer.